IN2014DN08294A - - Google Patents
Info
- Publication number
- IN2014DN08294A IN2014DN08294A IN8294DEN2014A IN2014DN08294A IN 2014DN08294 A IN2014DN08294 A IN 2014DN08294A IN 8294DEN2014 A IN8294DEN2014 A IN 8294DEN2014A IN 2014DN08294 A IN2014DN08294 A IN 2014DN08294A
- Authority
- IN
- India
- Prior art keywords
- iron
- iron deficiency
- prophylaxis
- iii
- treatment
- Prior art date
Links
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 abstract 1
- 206010022971 Iron Deficiencies Diseases 0.000 abstract 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12163308 | 2012-04-05 | ||
PCT/EP2013/057071 WO2013150087A1 (de) | 2012-04-05 | 2013-04-04 | Fe (iii) - pyrazin - komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN08294A true IN2014DN08294A (xx) | 2015-05-15 |
Family
ID=48045554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN8294DEN2014 IN2014DN08294A (xx) | 2012-04-05 | 2013-04-04 |
Country Status (12)
Country | Link |
---|---|
US (1) | US9439910B2 (xx) |
EP (1) | EP2833890B1 (xx) |
JP (1) | JP2015512436A (xx) |
KR (1) | KR20140143832A (xx) |
CN (1) | CN104203245A (xx) |
AU (1) | AU2013244955A1 (xx) |
CA (1) | CA2864577A1 (xx) |
ES (1) | ES2623300T3 (xx) |
IN (1) | IN2014DN08294A (xx) |
MX (1) | MX2014011886A (xx) |
RU (1) | RU2014144404A (xx) |
WO (1) | WO2013150087A1 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111714470B (zh) * | 2020-05-27 | 2022-04-08 | 天津瑞益瑞美生物技术有限公司 | 一种兽用肠溶乙二胺四乙酸铁钠预混剂及其制备方法 |
WO2023244831A1 (en) * | 2022-06-17 | 2023-12-21 | Regents Of The University Of Minnesota | Iron complexes and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
GB8325496D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
-
2013
- 2013-04-04 IN IN8294DEN2014 patent/IN2014DN08294A/en unknown
- 2013-04-04 ES ES13713912.7T patent/ES2623300T3/es active Active
- 2013-04-04 JP JP2015503874A patent/JP2015512436A/ja active Pending
- 2013-04-04 MX MX2014011886A patent/MX2014011886A/es unknown
- 2013-04-04 AU AU2013244955A patent/AU2013244955A1/en not_active Abandoned
- 2013-04-04 KR KR20147031197A patent/KR20140143832A/ko not_active Application Discontinuation
- 2013-04-04 WO PCT/EP2013/057071 patent/WO2013150087A1/de active Application Filing
- 2013-04-04 CA CA 2864577 patent/CA2864577A1/en not_active Abandoned
- 2013-04-04 EP EP13713912.7A patent/EP2833890B1/de not_active Not-in-force
- 2013-04-04 US US14/390,781 patent/US9439910B2/en active Active
- 2013-04-04 RU RU2014144404A patent/RU2014144404A/ru not_active Application Discontinuation
- 2013-04-04 CN CN201380018838.7A patent/CN104203245A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
US20150119374A1 (en) | 2015-04-30 |
EP2833890B1 (de) | 2017-02-01 |
US9439910B2 (en) | 2016-09-13 |
WO2013150087A1 (de) | 2013-10-10 |
ES2623300T3 (es) | 2017-07-10 |
AU2013244955A1 (en) | 2014-10-23 |
EP2833890A1 (de) | 2015-02-11 |
JP2015512436A (ja) | 2015-04-27 |
KR20140143832A (ko) | 2014-12-17 |
RU2014144404A (ru) | 2016-05-27 |
CA2864577A1 (en) | 2013-10-05 |
CN104203245A (zh) | 2014-12-10 |
MX2014011886A (es) | 2014-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019502809A1 (en) | Substituted tricyclic compounds as fgfr inhibitors | |
TN2015000278A1 (en) | Autotaxin inhibitors | |
PH12015500825A1 (en) | Substituted benzene compounds | |
MX2020010535A (es) | Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide. | |
MX2015006152A (es) | Compuestos de aminopirimidina como inhibidores de mutantes de egfr que contienen t7 9 0m. | |
IN2014MN02049A (xx) | ||
NZ628294A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
GEP20186899B (en) | 6 - alkynyl pyridines as smac mimetics | |
MX2015011193A (es) | Compuestos antivirales. | |
TN2012000457A1 (en) | Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias | |
MY166449A (en) | Pharmaceutical composition of rosuvastatin calcium | |
MX2014015884A (es) | Compuestos antivirales. | |
MY171802A (en) | Compositions comprising vortioxetine and donepezil | |
MX2015011198A (es) | Compuestos antivirales. | |
IN2015DN00950A (xx) | ||
MX2015009176A (es) | Derivados de triazola antivirales. | |
IN2015DN02109A (xx) | ||
IN2014DN08294A (xx) | ||
MX2015010892A (es) | Compuestos antivirales. | |
TN2013000379A1 (en) | Fe(iii) complexes for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias | |
MX2015007974A (es) | Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de la deficiencia de hierro y las anemias por deficiencia de hierro. | |
IN2013MU03317A (xx) | ||
MX2015013736A (es) | Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de deficiencia de hierro y anemia por deficiencia de hierro. | |
MX2015011126A (es) | Compuestos antivirales. | |
MX2015011125A (es) | Compuestos antivirales. |